他汀类药物在脑卒中预防研究中的临床证据

[1] 稳定型冠心病患者阿托伐他汀强化降脂治疗的作用 [J]. 世界核心医学期刊文摘(心脏病学分册), 2005, (11) : 30 - 31

[2] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial[J] . The Lancet . 2003 (9364)

[3] Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial[J] . James Shepherd,Gerard J Blauw,Michael B Murphy,Edward LEM Bollen,Brendan M Buckley,Stuart M Cobbe,Ian Ford,Allan Gaw,Michael Hyland,J Wouter Jukema,Adriaan M Kamper,Peter W Macfarlane,A Edo Meinders,John Norrie,Chris J Packard,Ivan J Perry,David J Stott,Brian J Sweeney,Gillian Twomey,Rudi GJ Westendorp.The Lancet . 2002 (9346)

[4] MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial[J] . The Lancet . 2002 (9326)

[5] Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels: Subgroup Analyses in the Cholesterol And Recurrent Events (CARE) Trial[J] . Ronald B. Goldberg,Margot J. Mellies,Frank M. Sacks,Lemuel A. Moye,Barbara V. Howard,William James Howard,Barry R. Davis,Thomas G. Cole,Marc A. Pfeffer,Eugene Braunwald.Circulation . 1998 (23)

[1] 稳定型冠心病患者阿托伐他汀强化降脂治疗的作用 [J]. 世界核心医学期刊文摘(心脏病学分册), 2005, (11) : 30 - 31

[2] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial[J] . The Lancet . 2003 (9364)

[3] Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial[J] . James Shepherd,Gerard J Blauw,Michael B Murphy,Edward LEM Bollen,Brendan M Buckley,Stuart M Cobbe,Ian Ford,Allan Gaw,Michael Hyland,J Wouter Jukema,Adriaan M Kamper,Peter W Macfarlane,A Edo Meinders,John Norrie,Chris J Packard,Ivan J Perry,David J Stott,Brian J Sweeney,Gillian Twomey,Rudi GJ Westendorp.The Lancet . 2002 (9346)

[4] MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial[J] . The Lancet . 2002 (9326)

[5] Cardiovascular Events and Their Reduction With Pravastatin in Diabetic and Glucose-Intolerant Myocardial Infarction Survivors With Average Cholesterol Levels: Subgroup Analyses in the Cholesterol And Recurrent Events (CARE) Trial[J] . Ronald B. Goldberg,Margot J. Mellies,Frank M. Sacks,Lemuel A. Moye,Barbara V. Howard,William James Howard,Barry R. Davis,Thomas G. Cole,Marc A. Pfeffer,Eugene Braunwald.Circulation . 1998 (23)